Biblio Discovery — Demo Discovery Service

18 hasil untuk "Beth Apsel"

Menampilkan 1–18 · 1,42 detik · RSS

  1. Artikel Jurnal

    Sickle cell, thalassemia, and heat: risk estimates and equity policy considerations from an exploratory timeseries study in California

    Dharshani Pearson; Beth Apsel Winger; Keita Ebisu

    Environmental Research: Health, Vol. 3 No. 4 · 2025 · Inggris · DOAJ Scopus

    People born with hemoglobinopathies, such as sickle cell disease and thalassemia, as well as people who are carriers for these disorders [sickle cell trait (SCT), thalassemia trait or thalassemia minor (TM)], may experience increased symptom-triggers and related illnesses from heat because their…

  2. Artikel Jurnal

    A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer

    Amith Rangarajan; Ilona Sviezhentseva; Emma Gunderson dkk.

    Frontiers in Oncology, Vol. 15 · 2025 · Inggris · DOAJ Scopus

    IntroductionClinical workflows to analyze variants of unknown significance (VUSs) found in clinical next generation sequencing (NGS) are labor intensive, requiring manual analysis of published data for each variant. There is a strong need for tools and resources that provide a consistent way to…

  3. Artikel Jurnal Teks lengkap

    Assessing the Activation of Tyrosine Kinase KIT through Free Energy Calculations

    Sandoval-Pérez, Angélica; Winger, Beth Apsel; Jacobson, Matthew P.

    J Chem Theory Comput · 2022 · Inggris · PubMed Central

    [Image: see text] KIT is a type 3 receptor tyrosine kinase that plays a crucial role in cellular growth and proliferation. Mutations in KIT can dysregulate its active–inactive equilibrium. Activating mutations drive cancer growth, while deactivating mutations result in the loss of skin and hair…

  4. Artikel Jurnal

    A Guidance for Concomitant Drug Reconciliation Prior to Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults

    Beth Apsel Winger; Susie E. Long; Jordan Brooks dkk.

    Frontiers in Pediatrics, Vol. 9 · 2021 · Inggris · DOAJ Scopus

    Pediatric diseases treated by allogeneic hematopoietic stem cell transplantation (alloHCT) are complex and associated with significant comorbidities and medication requirements that can complicate the transplant process. It is critical to reconcile pre-transplant concomitant medications (pcon-meds)…

  5. Artikel Jurnal Teks lengkap

    Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

    Morris E Feldman; Beth Apsel; Aino Uotila dkk.

    PLoS Biology, Vol. 7 No. 2 · 2009 · Inggris · PLOS Scopus

    The mammalian target of rapamycin (mTOR) regulates cell growth and survival by integrating nutrient and hormonal signals. These signaling functions are distributed between at least two distinct mTOR protein complexes: mTORC1 and mTORC2. mTORC1 is sensitive to the selective inhibitor rapamycin and…

    Juga tersedia di: DOAJ

  6. Artikel Jurnal Teks lengkap

    Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population

    Shukla, Praveen; Goswami, Srijib; Keizer, Ron J. dkk.

    Front Pharmacol · 2020 · Inggris · PubMed Central

    INTRODUCTION: Population pharmacokinetic (PK) studies demonstrate model-based dosing for busulfan that incorporates body size and age improve clinical target attainment as compared to weight-based regimens. Recently, for clinical dosing of busulfan and TDM, our institution transitioned to a…

    Juga tersedia di: DOAJ

  7. Artikel Jurnal Teks lengkap

    Quantification of N, N’ N”-triethylenethiophosphoramide, N, N”-triethylenephosphoramide, cyclophosphamide, and 4-hydroxy-cyclophosphamide in microvolume human plasma to support neonatal and pediatric drug studies

    Huang, Liusheng; Winger, Beth Apsel; Cheah, Vincent dkk.

    J Chromatogr Open · 2022 · Inggris · PubMed Central

    N, N’ N”-triethylenethiophosphoramide (thiotepa) and cyclophosphamide (CP) are alkylating agents used for a variety of malignant and non-malignant disorders. Both drugs are metabolized by cytochrome P450 enzymes to form active metabolites. To support pharmacokinetic studies of thiotepa and CP in…

    Juga tersedia di: DOAJ

  8. Artikel Jurnal Teks lengkap

    Mycobacterium bovis enterocolitis in an immunocompromised host

    Winger, Beth Apsel; Foy, Eileen; Sud, Sohil R. dkk.

    J Pediatr Gastroenterol Nutr · 2016 · Inggris · PubMed Central

  9. Artikel Jurnal Teks lengkap

    ATP-competitive inhibitors midostaurin and avapritinib have distinct resistance profiles in exon 17-mutant KIT

    Winger, Beth Apsel; Cortopassi, Wilian A.; Ruiz, Diego Garrido dkk.

    Cancer Res · 2019 · Inggris · PubMed Central

    KIT is a type-3 receptor tyrosine kinase that is frequently mutated at exon 11 or 17 in a variety of cancers. First generation KIT tyrosine kinase inhibitors (TKIs) are ineffective against KIT exon 17 mutations, which favor an active conformation that prevents these TKIs from binding. The…

  10. Artikel Jurnal Teks lengkap

    Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies

    Marinoff, Amanda E.; Thrall, Allyson; Aaronson, Kathryn dkk.

    Pediatr Blood Cancer · 2025 · Inggris · PubMed Central

    BACKGROUND: Thrombopoietin receptor agonists (TPO-RAs) have demonstrated efficacy in treating clinically significant thrombocytopenia, including chemotherapy-induced thrombocytopenia in adults. However, data regarding their safety and efficacy in pediatric, adolescents, and young adult (AYA)…

  11. Artikel Jurnal

    Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes

    Deeti J. Pithadia; Marina J. Heskel; Arman Shotayev dkk.

    Blood Vessels, Thrombosis & Hemostasis, Vol. 3 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract: Vascular anomalies (VAs) are complex, highly morbid conditions that are increasingly managed by hematologists with targeted therapies. They are often driven by activating mutations in the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway. Alpelisib, a…

  12. Artikel Jurnal Teks lengkap

    Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation

    Jordan T. Brooks; Belen P. Solans; Ying Lu dkk.

    Pharmaceutics, Vol. 14 No. 11 · 2022 · Inggris · DOAJ Scopus

    Fludarabine is a nucleoside analog with antileukemic and immunosuppressive activity commonly used in allogeneic hematopoietic cell transplantation (HCT). Several fludarabine population pharmacokinetic (popPK) and pharmacodynamic models have been published enabling the movement towards precision…

  13. Artikel Jurnal Teks lengkap

    Integration of genomic sequencing drives therapeutic targeting of PDGFRA in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma

    Paolino, Jonathan; Dimitrov, Boris; Winger, Beth Apsel dkk.

    Clin Cancer Res · 2023 · Inggris · PubMed Central

    PURPOSE: Patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (T-LBL) have limited therapeutic options. Clinical use of genomic profiling provides an opportunity to identify targetable alterations to inform therapy. EXPERIMENTAL DESIGN: We…

  14. Artikel Jurnal Teks lengkap

    Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-risk Leukemias: A Report from the LEAP Consortium

    Pikman, Yana; Tasian, Sarah K.; Sulis, Maria Luisa dkk.

    Cancer Discov · 2021 · Inggris · PubMed Central

    Despite a remarkable increase in the genomic profiling of cancer, integration of genomic discoveries into clinical care has lagged behind. We report the feasibility of rapid identification of targetable mutations in 153 pediatric patients with relapsed/refractory or high-risk leukemias enrolled on…